Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.3%

3 terminated out of 57 trials

Success Rate

89.7%

+3.1% vs benchmark

Late-Stage Pipeline

11%

6 trials in Phase 3/4

Results Transparency

4%

1 of 26 completed with results

Key Signals

1 with results90% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (20)
Early P 1 (1)
P 2 (8)
P 3 (1)
P 4 (5)

Trial Status

Completed26
Unknown14
Withdrawn6
Recruiting3
Terminated3
Active Not Recruiting3

Trial Success Rate

89.7%

Benchmark: 86.5%

Based on 26 completed trials

Clinical Trials (57)

Showing 20 of 20 trials
NCT07546448Not Yet Recruiting

Serum Electrolytes and Contrast-Induced Nephropathy in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment

NCT03116139Not ApplicableTerminated

Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT

NCT07459413Not ApplicableRecruiting

Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED

NCT04864847Active Not Recruiting

Clinical Validation of the RENISCHEM L-FABP POC Assay

NCT07291375Early Phase 1Not Yet RecruitingPrimary

Role of Amlodipine in Reduction of CIN

NCT07184918Not ApplicableCompletedPrimary

Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography

NCT05283512Not ApplicableRecruitingPrimary

Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease

NCT07022626Not ApplicableCompleted

Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients

NCT04163484Completed

Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease

NCT04225013Completed

Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy

NCT06429345Phase 4RecruitingPrimary

Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients.

NCT06418542Phase 4Active Not RecruitingPrimary

Contrast Nephropathy Associated FFA

NCT04606056Active Not Recruiting

Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans

NCT04598516Withdrawn

Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30

NCT04597892Withdrawn

Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast

NCT04603261Withdrawn

Time to Excretion of Contrast, a Maastricht Prospective Observational Study

NCT03305874CompletedPrimary

Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization

NCT05271448Not ApplicableUnknownPrimary

Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

NCT04877847Not ApplicableTerminatedPrimary

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

NCT04592406Completed

Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30

Scroll to load more

Research Network

Activity Timeline